SCHEMBL14554383

SCHEMBL14554383

COc1ccc2nc(N(C)CCN)sc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.55
CYP2C19 P33261 2/20 0.55
CYP3A4 P08684 1/20 0.55
PDK1 Q15118 1/20 0.50
APP P05067 3/20 0.49
RAB9A P51151 3/20 0.49
LMNA P02545 2/20 0.49
GLA P06280 1/20 0.49
GAA P10253 1/20 0.49
TP53 P04637 1/20 0.49
CYP2C9 P11712 1/20 0.49
WNT3A P56704 1/20 0.48
CYP2D6 P10635 1/20 0.48
MAPT P10636 4/20 0.47
MEN1 O00255 2/20 0.47
NPC1 O15118 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
NFKB1 P19838 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9036775 0.85 LMNA (0.55) CYP1A2CYP2C19CYP3A4PDK1APP
SCHEMBL11011214 0.81 CYP1A2 (0.48) CYP1A2CYP2C19CYP3A4PDK1APP
SCHEMBL14554495 0.77 NPC1 (0.49) CYP1A2CYP2C19CYP3A4APPRAB9A
SCHEMBL14484796 0.77 CYP1A2 (0.60) CYP1A2CYP2C19RAB9ALMNAGAA
SCHEMBL24086123 0.75 CYP1A2 (0.51) CYP1A2CYP2C19CYP3A4PDK1APP
SCHEMBL3242801 0.74 CYP1A2 (0.64) CYP1A2CYP2C19CYP3A4PDK1APP
SCHEMBL23965817 0.73 SMN1; SMN2 (0.48) CYP1A2RAB9ALMNAGLAGAA
SCHEMBL29683488 0.71 CYP3A4 (1.00) CYP1A2CYP2C19CYP3A4PDK1APP
SCHEMBL22358 0.71 CYP3A4 (1.00) CYP1A2CYP2C19CYP3A4PDK1APP
SCHEMBL3752321 0.70 SMN1; SMN2 (0.51) APPRAB9ALMNAGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013006408-A1 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2013-01-10 WO disclosed